A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Clinical trial NCT01357850 · COMPLETED
Trial details
- NCT number
- NCT01357850
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-15
- Primary completion
- 2012-09-18
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.